The DOI matches its Crossref record; 337 of the 337 references it cites were found in a registry or an index.
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Open accessAbstract
Infections with Pseudomonas aeruginosa have become a concerning threat in hospital-acquired infections and for cystic fibrosis patients. The major problem leading to high mortality lies in the appearance of drug-resistant strains. Therefore, a vast number of approaches to develop novel anti-infectives is currently pursued. These diverse strategies span from killing (new antibiotics) to disarming (antivirulence) the pathogen. Particular emphasis lies on the development of compounds that inhibit biofilms formed in chronic infections to restore susceptibility toward antibiotics. Numerous promising results are summarized in this perspective. Antibiotics with a novel mode of action will be needed to avoid cross resistance against currently used therapeutic agents. Importantly, antivirulence drugs are expected to yield a significantly reduced rate of resistance development. Most developments are still far from the application. It can however be expected that combination therapies, also containing antivirulence agents, will pave the way toward novel treatment options against P. aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Miller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537
Quantification of biofilm structures by the novel computer program comstat
Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C., Givskov, M., Ersbøll, B. K., & Molin, S. (2000) · Microbiology · doi:10.1099/00221287-146-10-2395 · Cited by 2,179
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Church, D., Elsayed, S., Reid, O., Winston, B., & Lindsay, R. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.403-434.2006 · Cited by 1,876
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Principles of c-di-GMP signalling in bacteria
Hengge, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2109 · Cited by 1,578
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Anti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373
Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa
Pesci, E. C., Milbank, J. B. J., Pearson, J. P., McKnight, S., Kende, A. S., Greenberg, E. P., & Iglewski, B. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11229 · Cited by 1,113
A Virulence Locus of Pseudomonas aeruginosa Encodes a Protein Secretion Apparatus
Mougous, J. D., Cuff, M. E., Raunser, S., Shen, A., Zhou, M., Gifford, C. A., Goodman, A. L., Joachimiak, G., Ordoñez, C. L., Lory, S., et al. (2006) · Science · doi:10.1126/science.1128393 · Cited by 1,103
Edwards, R., & Harding, K. G. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200404000-00004 · Cited by 1,099
Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants
Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes‐Jørgensen, A., Molin, S., & Tolker‐Nielsen, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03525.x · Cited by 1,020
Multivalency as a Chemical Organization and Action Principle
Fasting, C., Schalley, C. A., Weber, M., Seitz, O., Hecht, S., Koksch, B., Dernedde, J., Graf, C., Knapp, E., & Haag, R. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201114 · Cited by 993
Bacterial Invasion: The Paradigms of Enteroinvasive Pathogens
Cossart, P., & Sansonetti, P. J. (2004) · Science · doi:10.1126/science.1090124 · Cited by 981
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
A Type VI Secretion System of Pseudomonas aeruginosa Targets a Toxin to Bacteria
Hood, R. D., Singh, P., Hsu, F., Güvener, T., Carl, M. A., Trinidad, R. R. S., Silverman, J. M., Ohlson, B. B., Hicks, K. G., Plemel, R. L., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2009.12.007 · Cited by 932
Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa
Pesci, E. C., Pearson, J. P., Seed, P. C., & Iglewski, B. H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.10.3127-3132.1997 · Cited by 889
Effects of biofilm structures on oxygen distribution and mass transport
de Beer, D., Stoodley, P., Roe, F., & Lewandowski, Z. (1994) · Biotechnology and Bioengineering · doi:10.1002/bit.260431118 · Cited by 876
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
Expression of Pseudomonas aeruginosa Virulence Genes Requires Cell-to-Cell Communication
Passador, L., Cook, J. M., Gambello, M. J., Rust, L., & Iglewski, B. H. (1993) · Science · doi:10.1126/science.8493556 · Cited by 857
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Exploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820
Iron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø., & Høiby, N. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.002 · Cited by 764
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
O’Loughlin, C. T., Miller, L. C., Siryaporn, A., Drescher, K., Semmelhack, M. F., & Bassler, B. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316981110 · Cited by 744
The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
Gambello, M. J., & Iglewski, B. H. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.9.3000-3009.1991 · Cited by 725
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
C‐di‐GMP: the dawning of a novel bacterial signalling system
Römling, U., Gomelsky, M., & Galperin, M. Y. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04697.x · Cited by 685
Galloway, W. R. J. D., Hodgkinson, J. T., Bowden, S. D., Welch, M., & Spring, D. R. (2011) · Chemical Reviews · doi:10.1021/cr100109t · Cited by 665
Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30783 · Cited by 661
All tangled up: how cells direct, manage and exploit topoisomerase function
Vos, S. M., Tretter, E. M., Schmidt, B. H., & Berger, J. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3228 · Cited by 650
Mechanisms of Cyclic-di-GMP Signaling in Bacteria
Jenal, U., & Malone, J. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090423 · Cited by 647
Déziel, E., Lépine, F., Milot, S., He, J., Mindrinos, M. N., Tompkins, R. G., & Rahme, L. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307694100 · Cited by 637
Multidrug-Resistant Pseudomonas aeruginosa : Risk Factors and Clinical Impact
Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.43-48.2006 · Cited by 617
Pseudomonas biofilm matrix composition and niche biology
Mann, E. E., & Wozniak, D. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00322.x · Cited by 606
Acyl homoserine-lactone quorum-sensing signal generation
Parsek, M. R., Val, D. L., Hanzelka, B. L., Cronan, J. E., & Greenberg, E. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4360 · Cited by 592
Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584
Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl
Franklin, M. J., Nivens, D. E., Weadge, J. T., & Howell, P. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00167 · Cited by 576
Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa.
Ochsner, U. A., & Reiser, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6424 · Cited by 569
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 567
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections
Lebeaux, D., Chauhan, A., Rendueles, O., & Beloin, C. (2013) · Pathogens · doi:10.3390/pathogens2020288 · Cited by 545
Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands
Cecioni, S., Imberty, A., & Vidal, S. (2015) · Chemical Reviews · doi:10.1021/cr500303t · Cited by 544
Borlee, B. R., Goldman, A. D., Murakami, K., Samudrala, R., Wozniak, D. J., & Parsek, M. R. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06991.x · Cited by 543
Positive Correlation between Virulence of Pseudomonas aeruginosa Mutants in Mice and Insects
Jander, G., Rahme, L. G., & Ausubel, F. M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.13.3843-3845.2000 · Cited by 541
Multivalent glycoconjugates as anti-pathogenic agents
Bernardi, A., Jiménez-Barbero, J., Casnati, A., De Castro, C., Darbre, T., Fieschi, F., Finne, J., Funken, H., Jaeger, K.-E., Lahmann, M., et al. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35408j · Cited by 537
Kulesekara, H., Lee, V., Brencic, A., Liberati, N., Urbach, J., Miyata, S., Lee, D. G., Neely, A. N., Hyodo, M., Hayakawa, Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511090103 · Cited by 533
Targeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Antimicrobial peptides stage a comeback
Fox, J. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2572 · Cited by 524
Quorum sensing inhibitors: a bargain of effects
Rasmussen, T. B., & Givskov, M. (2006) · Microbiology · doi:10.1099/mic.0.28601-0 · Cited by 523
Pyoverdin is essential for virulence of Pseudomonas aeruginosa
Meyer, J. M., Neely, A., Stintzi, A., Georges, C., & Holder, I. A. (1996) · Infection and Immunity · doi:10.1128/iai.64.2.518-523.1996 · Cited by 521
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
Finck‐Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener‐Kronish, J. P., Fleiszig, S. M. J., Wu, C., Mende‐Mueller, L., & Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4891851.x · Cited by 518
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism
Froelich-Ammon, S. J., & Osheroff, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21429 · Cited by 505
Epithelial antimicrobial peptides in host defense against infection
Bals, R. (2000) · Respiratory Research · doi:10.1186/rr25 · Cited by 498
Nonrandom Distribution of Pseudomonas aeruginosa and Staphylococcus aureus in Chronic Wounds
Fazli, M., Bjarnsholt, T., Kirketerp-Møller, K., Jørgensen, B., Andersen, A. S., Krogfelt, K. A., Givskov, M., & Tolker-Nielsen, T. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01395-09 · Cited by 490
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I. A., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E., Søren, M., et al. (1999) · Microbiology · doi:10.1099/13500872-145-6-1349 · Cited by 484
Structural basis of activity and allosteric control of diguanylate cyclase
Chan, C., Paul, R., Samoray, D., Amiot, N. C., Giese, B., Jenal, U., & Schirmer, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406134101 · Cited by 477
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Döring, G., Flume, P., Heijerman, H., & Elborn, J. S. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.10.004 · Cited by 474
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
Yahr, T. L., Vallis, A. J., Hancock, M. K., Barbieri, J. T., & Frank, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13899 · Cited by 464
Roy‐Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., & Wiener‐Kronish, J. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/320737 · Cited by 455
Bacterial and Fungal Biofilm Infections
Lynch, A. S., & Robertson, G. T. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.110106.132000 · Cited by 447
Wu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
Mechanisms of Therapeutic Activity for Gallium
Bernstein, L. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01383-8 · Cited by 446
Ochsner, U. A., Koch, A. K., Fiechter, A., & Reiser, J. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.7.2044-2054.1994 · Cited by 429
Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa
Persat, A., Inclan, Y. F., Engel, J. N., Stone, H. A., & Gitai, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502025112 · Cited by 424
A cell-cell communication signal integrates quorum sensing and stress response
Lee, J., Wu, J., Deng, Y., Wang, J., Wang, C., Wang, J., Chang, C., Dong, Y., Williams, P., & Zhang, L.-H. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1225 · Cited by 416
Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors
Russell, A. B., LeRoux, M., Hathazi, K., Agnello, D. M., Ishikawa, T., Wiggins, P. A., Wai, S. N., & Mougous, J. D. (2013) · Nature · doi:10.1038/nature12074 · Cited by 414
The Pseudomonas Quinolone Signal Regulates rhl Quorum Sensing in Pseudomonas aeruginosa
McKnight, S. L., Iglewski, B. H., & Pesci, E. C. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.10.2702-2708.2000 · Cited by 412
Antibacterial Agents That Inhibit Lipid A Biosynthesis
Onishi, H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M.-H., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., et al. (1996) · Science · doi:10.1126/science.274.5289.980 · Cited by 410
New antibiotics for bad bugs: where are we?
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-22 · Cited by 403
Secretion of Yop proteins by Yersiniae
Michiels, T., Wattiau, P., Brasseur, R., Ruysschaert, J. M., & Cornelis, G. (1990) · Infection and Immunity · doi:10.1128/iai.58.9.2840-2849.1990 · Cited by 402
Wolfgang, M. C., Kulasekara, B. R., Liang, X., Boyd, D., Wu, K., Yang, Q., Miyada, C. G., & Lory, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832438100 · Cited by 400
Hauser, A. R., Cobb, E., Bodí, M., Mariscal, D., Vallés, J., Engel, J. N., & Rello, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00005 · Cited by 399
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W., & Deretic, V (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8377 · Cited by 392
Bactericidal antisense effects of peptide–PNA conjugates
Good, L., Awasthi, S. K., Dryselius, R., Larsson, O., & Nielsen, P. E. (2001) · Nature Biotechnology · doi:10.1038/86753 · Cited by 391
Regulation of Pseudomonas Quinolone Signal Synthesis in Pseudomonas aeruginosa
Wade, D. S., Calfee, M. W., Rocha, E. R., Ling, E. A., Engstrom, E., Coleman, J. P., & Pesci, E. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4372-4380.2005 · Cited by 387
Tielker, D., Hacker, S., Loris, R., Strathmann, M., Wingender, J., Wilhelm, S., Rosenau, F., & Jaeger, K.-E. (2005) · Microbiology · doi:10.1099/mic.0.27701-0 · Cited by 386
The bacterial type VI secretion machine: yet another player for protein transport across membranes
Filloux, A., Hachani, A., & Bleves, S. (2008) · Microbiology · doi:10.1099/mic.0.2008/016840-0 · Cited by 378
An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal
Harmsen, M., Yang, L., Pamp, S. J., & Tolker-Nielsen, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00690.x · Cited by 376
The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa
Diggle, S. P., Stacey, R. E., Dodd, C., Cámara, M., Williams, P., & Winzer, K. (2006) · Environmental Microbiology · doi:10.1111/j.1462-2920.2006.001001.x · Cited by 375
The exoenzyme S regulon of Pseudomonas aeruginosa
Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.6251991.x · Cited by 370
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin
Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H., & Zasloff, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.782 · Cited by 359
Overhage, J., Bains, M., Brazas, M. D., & Hancock, R. E. W. (2008) · Journal of Bacteriology · doi:10.1128/jb.01659-07 · Cited by 358
Biofilms and catheter-associated urinary tract infections
Saint, S., & Chenoweth, C. E. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00011-4 · Cited by 355
Cao, H., Krishnan, G., Goumnerov, B., Tsongalis, J., Tompkins, R., & Rahme, L. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251465298 · Cited by 348
c-di-GMP-mediated regulation of virulence and biofilm formation
Cotter, P. A., & Stibitz, S. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.12.006 · Cited by 344
The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa – a review
Hahn, H. P. (1997) · Gene · doi:10.1016/s0378-1119(97)00116-9 · Cited by 334
Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B. P., & Faure, K. (2009) · Infection and Immunity · doi:10.1128/iai.01204-08 · Cited by 325
Quorum Quenching by an N -Acyl-Homoserine Lactone Acylase from Pseudomonas aeruginosa PAO1
Sio, C. F., Otten, L. G., Cool, R. H., Diggle, S. P., Braun, P. G., Bos, R., Daykin, M., Cámara, M., Williams, P., & Quax, W. J. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1673-1682.2006 · Cited by 322
Small Molecule Inhibitors of Bacterial Quorum Sensing and Biofilm Formation
Geske, G. D., Wezeman, R. J., Siegel, A. P., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0530321 · Cited by 320
Induction and Inhibition of Pseudomonas aeruginosa Quorum Sensing by Synthetic Autoinducer Analogs
Smith, K. M., Bu, Y., & Suga, H. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00002-4 · Cited by 320
Therapeutic applications of carbon monoxide-releasing molecules
Motterlini, R., Mann, B. E., & Foresti, R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1305 · Cited by 315
Urinary tract infections caused by Pseudomonas aeruginosa: A minireview
Mittal, R., Aggarwal, S., Sharma, S., Chhibber, S., & Harjai, K. (2009) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2009.08.003 · Cited by 312
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., & DeGrado, W. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811818106 · Cited by 308
Fleiszig, S. M., Wiener-Kronish, J. P., Miyazaki, H., Vallas, V, Mostov, K. E., Kanada, D., Sawa, T., Yen, T. S., & Frank, D. W. (1997) · Infection and Immunity · doi:10.1128/iai.65.2.579-586.1997 · Cited by 307
Regulation of biofilm formation in P seudomonas and B urkholderia species
Fazli, M., Almblad, H., Rybtke, M. L., Givskov, M., Eberl, L., & Tolker‐Nielsen, T. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12448 · Cited by 306
MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR‐class regulatory protein, has dual ligands
Xiao, G., Déziel, E., He, J., Lépine, F., Lesic, B., Castonguay, M., Milot, S., Tampakaki, A. P., Stachel, S. E., & Rahme, L. G. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05462.x · Cited by 301
Quorum quenching quandary: resistance to antivirulence compounds
Maeda, T., García-Contreras, R., Pu, M., Sheng, L., Garcia, L. R., Tomás, M., & Wood, T. K. (2012) · The ISME Journal · doi:10.1038/ismej.2011.122 · Cited by 300
Looking for Chinks in the Armor of Bacterial Biofilms
Monroe, D. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050307 · Cited by 300
Protein Secretion in Gram-Negative Bacteria via the Autotransporter Pathway
Dautin, N., & Bernstein, H. D. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093233 · Cited by 296
Type IV Pilin Structure and Assembly
Craig, L., Taylor, R. K., Pique, M. E., Adair, B. D., Arvai, A. S., Singh, M., Lloyd, S. J., Shin, D. S., Getzoff, E. D., Yeager, M., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00170-9 · Cited by 288
ExoU is a potent intracellular phospholipase
Sato, H., & Frank, D. W. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04194.x · Cited by 287
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Mitchell, E., Houles, C., Sudakevitz, D., Wimmerova, M., Gautier, C., Pérez, S., Wu, A. M., Gilboa-Garber, N., & Imberty, A. (2002) · Nature Structural Biology · doi:10.1038/nsb865 · Cited by 282
Siderophores as drug delivery agents: application of the “Trojan Horse” strategy
Möllmann, U., Heinisch, L., Bauernfeind, A., Köhler, T., & Ankel-Fuchs, D. (2009) · BioMetals · doi:10.1007/s10534-009-9219-2 · Cited by 274
Bacterial protein secretion through the translocase nanomachine
Papanikou, E., Karamanou, S., & Economou, A. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1771 · Cited by 273
Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., Tzika, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004321 · Cited by 273
Siderophore activity of pyoverdin for Pseudomonas aeruginosa
Cox, C. D., & Adams, P. (1985) · Infection and Immunity · doi:10.1128/iai.48.1.130-138.1985 · Cited by 271
Jiang, F., Waterfield, N. R., Yang, J., Yang, G., & Jin, Q. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.04.010 · Cited by 270
Clinical and Experimental Applications of Sodium Phenylbutyrate
Iannitti, T., & Palmieri, B. (2011) · Drugs in R & D · doi:10.1007/bf03259725 · Cited by 270
Miyata, S., Casey, M., Frank, D. W., Ausubel, F. M., & Drenkard, E. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2404-2413.2003 · Cited by 269
The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei
Burtnick, M. N., Brett, P. J., Harding, S. V., Ngugi, S. A., Ribot, W. J., Chantratita, N., Scorpio, A., Milne, T. S., Dean, R. E., Fritz, D. L., et al. (2011) · Infection and Immunity · doi:10.1128/iai.01218-10 · Cited by 269
Recent advances toward a molecular mechanism of efflux pump inhibition
Opperman, T. J., & Nguyen, S. T. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00421 · Cited by 266
Ilangovan, A., Fletcher, M., Rampioni, G., Pustelny, C., Rumbaugh, K., Heeb, S., Cámara, M., Truman, A., Chhabra, S. R., Emsley, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003508 · Cited by 264
The Pseudomonas aeruginosa Lectins PA-IL and PA-IIL Are Controlled by Quorum Sensing and by RpoS
Winzer, K., Falconer, C., Garber, N. C., Diggle, S. P., Camara, M., & Williams, P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.22.6401-6411.2000 · Cited by 264
[2] Molecular tools for study of biofilm physiology
Christensen, B. B., Sternberg, C., Andersen, J. B., Palmer, R. J., Toftgaard Nielsen, A., Givskov, M., & Molin, S. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)10004-1 · Cited by 263
Johansson, E. M. V., Crusz, S. A., Kolomiets, E., Buts, L., Kadam, R. U., Cacciarini, M., Bartels, K.-M., Diggle, S. P., Cámara, M., Williams, P., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.009 · Cited by 263
Deslouches, B., Phadke, S. M., Lazarevic, V., Cascio, M., Islam, K., Montelaro, R. C., & Mietzner, T. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.316-322.2005 · Cited by 262
Jacob‐Dubuisson, F., Locht, C., & Antoine, R. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02278.x · Cited by 261
Renau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
Novel Pseudomonas aeruginosa Quorum-Sensing Inhibitors Identified in an Ultra-High-Throughput Screen
Müh, U., Schuster, M., Heim, R., Singh, A., Olson, E. R., & Greenberg, E. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00665-06 · Cited by 259
Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (Review)
Holland, I. B., Schmitt, L., & Young, J. (2005) · Molecular Membrane Biology · doi:10.1080/09687860500042013 · Cited by 258
Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA
Good, L., & Nielsen, P. E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-355 · Cited by 257
McGrath, S., Wade, D. S., & Pesci, E. C. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00849-8 · Cited by 255
Pseudomonas aeruginosa ExoS and ExoT
Barbieri, J. T., & Sun, J. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-004-0031-7 · Cited by 254
Glycomimetics and Glycodendrimers as High Affinity Microbial Anti‐adhesins
Imberty, A., Chabre, Y. M., & Roy, R. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200800700 · Cited by 252
The Pseudomonas aeruginosa Flagellar Cap Protein, FliD, Is Responsible for Mucin Adhesion
Arora, S. K., Ritchings, B. W., Almira, E. C., Lory, S., & Ramphal, R. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1000-1007.1998 · Cited by 247
Calfee, M. W., Coleman, J. P., & Pesci, E. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201328498 · Cited by 242
Geske, G. D., O'Neill, J. C., Miller, D. M., Mattmann, M. E., & Blackwell, H. E. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074135h · Cited by 237
Protein Secretion Systems in Pseudomonas aeruginosa: An Essay on Diversity, Evolution, and Function
Filloux, A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00155 · Cited by 229
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
[32] Pseudomonas aeruginosa lectins
Gilboa-Garber, N. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83034-6 · Cited by 223
Suarez, G., Sierra, J. C., Sha, J., Wang, S., Erova, T. E., Fadl, A. A., Foltz, S. M., Horneman, A. J., & Chopra, A. K. (2008) · Microbial Pathogenesis · doi:10.1016/j.micpath.2007.10.005 · Cited by 221
Inhibitors of Pathogen Intercellular Signals as Selective Anti-Infective Compounds
Lesic, B., Lépine, F., Déziel, E., Zhang, J., Zhang, Q., Padfield, K., Castonguay, M.-H., Milot, S., Stachel, S., Tzika, A. A., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030126 · Cited by 221
Pulmonary infections in patients with cystic fibrosis
RAJAN, S. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.31690 · Cited by 220
Frontal and stealth attack strategies in microbial pathogenesis
Merrell, D. S., & Falkow, S. (2004) · Nature · doi:10.1038/nature02760 · Cited by 213
Hoang, T. T., & Schweizer, H. P. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.17.5489-5497.1999 · Cited by 212
Composition, function, and regulation of T6SS in Pseudomonas aeruginosa
Chen, L., Zou, Y., She, P., & Wu, Y. C. (2015) · Microbiological Research · doi:10.1016/j.micres.2015.01.004 · Cited by 211
Type VI Secretion: Not Just for Pathogenesis Anymore
Jani, A. J., & Cotter, P. A. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.012 · Cited by 206
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
Gasink, L. B., Fishman, N. O., Weiner, M. G., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.029 · Cited by 206
Road to Clinical Efficacy: Challenges and Novel Strategies for Antimicrobial Peptide Development
Eckert, R. (2011) · Future Microbiology · doi:10.2217/fmb.11.27 · Cited by 204
Structural basis of calcium and galactose recognition by the lectin PA‐IL of Pseudomonas aeruginosa
Cioci, G., Mitchell, E. P., Gautier, C., Wimmerová, M., Sudakevitz, D., Pérez, S., Gilboa-Garber, N., & Imberty, A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01249-3 · Cited by 203
Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli
Opperman, T. J., Kwasny, S. M., Kim, H.-S., Nguyen, S. T., Houseweart, C., D'Souza, S., Walker, G. C., Peet, N. P., Nikaido, H., & Bowlin, T. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01866-13 · Cited by 202
Antibacterial Activities and Characterization of Novel Inhibitors of LpxC
Clements, J. M., Coignard, F., Johnson, I., Chandler, S., Palan, S., Waller, A., Wijkmans, J., & Hunter, M. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1793-1799.2002 · Cited by 201
Structure of the Pseudomonas aeruginosa acyl‐homoserinelactone synthase LasI
Gould, T. A., Schweizer, H. P., & Churchill, M. E. A. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04211.x · Cited by 200
Torcato, I. M., Huang, Y.-H., Franquelim, H. G., Gaspar, D., Craik, D. J., Castanho, M. A. R. B., & Troeira Henriques, S. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.12.002 · Cited by 200
Mislin, G. L. A., & Schalk, I. J. (2014) · Metallomics · doi:10.1039/c3mt00359k · Cited by 198
Inhibition of Quorum Sensing in Pseudomonas aeruginosa by N -Acyl Cyclopentylamides
Ishida, T., Ikeda, T., Takiguchi, N., Kuroda, A., Ohtake, H., & Kato, J. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02233-06 · Cited by 193
Suter, S., Schaad, U. B., Roux, L., Nydegger, U. E., & Waldvogel, F. A. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.4.523 · Cited by 192
Grönberg, A., Mahlapuu, M., Ståhle, M., Whately‐Smith, C., & Rollman, O. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12211 · Cited by 191
Wilhelm, S., Gdynia, A., Tielen, P., Rosenau, F., & Jaeger, K.-E. (2007) · Journal of Bacteriology · doi:10.1128/jb.00023-07 · Cited by 189
Covalent Inhibition of Bacterial Quorum Sensing
Amara, N., Mashiach, R., Amar, D., Krief, P., Spieser, S. A. H., Bottomley, M. J., Aharoni, A., & Meijler, M. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903292v · Cited by 188
Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections
Strateva, T., & Mitov, I. (2011) · Annals of Microbiology · doi:10.1007/s13213-011-0273-y · Cited by 185
Antibacterial Agents That Target Lipid A Biosynthesis in Gram-negative Bacteria
Jackman, J. E., Fierke, C. A., Tumey, L. N., Pirrung, M., Uchiyama, T., Tahir, S. H., Hindsgaul, O., & Raetz, C. R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11002 · Cited by 184
Chang, C.-Y., Krishnan, T., Wang, H., Chen, Y., Yin, W.-F., Chong, Y.-M., Tan, L. Y., Chong, T. M., & Chan, K.-G. (2014) · Scientific Reports · doi:10.1038/srep07245 · Cited by 176
Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity
Baumann, S., Herrmann, J., Raju, R., Steinmetz, H., Mohr, K. I., Hüttel, S., Harmrolfs, K., Stadler, M., & Müller, R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409964 · Cited by 176
A novel type II secretion system in Pseudomonas aeruginosa
Ball, G., Durand, É., Lazdunski, A., & Filloux, A. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02759.x · Cited by 176
Yang, L., Nilsson, M., Gjermansen, M., Givskov, M., & Tolker‐Nielsen, T. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06934.x · Cited by 172
Generation and Characterization of a Protective Monoclonal Antibody to Pseudomonas aeruginosa PcrV
Frank, D. W., Vallis, A. J., Wiener‐Kronish, J. P., Roy‐Burman, A., Spack, E. G., Mullaney, B. P., Megdoud, M., Marks, J. D., Fritz, R. B., & Sawa, T. (2002) · The Journal of Infectious Diseases · doi:10.1086/341069 · Cited by 171
New treatment options against gram-negative organisms
Bassetti, M., Ginocchio, F., & Mikulska, M. (2011) · Critical Care · doi:10.1186/cc9997 · Cited by 170
A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
Isaksson, J., Brandsdal, B. O., Engqvist, M., Flaten, G. E., Svendsen, J. S. M., & Stensen, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200450h · Cited by 169
Sequence Diversity of Pseudomonas aeruginosa : Impact on Population Structure and Genome Evolution
Kiewitz, C., & Tümmler, B. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3125-3135.2000 · Cited by 167
Ji, C. Y., Miller, P. A., & Miller, M. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303446w · Cited by 165
An Inhibitor of Gram-Negative Bacterial Virulence Protein Secretion
Felise, H. B., Nguyen, H. V., Pfuetzner, R. A., Barry, K. C., Jackson, S. R., Blanc, M.-P., Bronstein, P. A., Kline, T., & Miller, S. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.001 · Cited by 163
Zhou, P., & Barb, A. W. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108783497668 · Cited by 162
DNA Binding: a Novel Function of Pseudomonas aeruginosa Type IV Pili
van Schaik, E. J., Giltner, C. L., Audette, G. F., Keizer, D. W., Bautista, D. L., Slupsky, C. M., Sykes, B. D., & Irvin, R. T. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1455-1464.2005 · Cited by 161
Synthetic Antimicrobial Peptidomimetics with Therapeutic Potential
Haug, B. E., Stensen, W., Kalaaji, M., Rekdal, Ø., & Svendsen, J. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701600a · Cited by 160
Müsken, M., Di Fiore, S., Römling, U., & Häussler, S. (2010) · Nature Protocols · doi:10.1038/nprot.2010.110 · Cited by 160
Giltner, C. L., Van Schaik, E. J., Audette, G. F., Kao, D., Hodges, R. S., Hassett, D. J., & Irvin, R. T. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05002.x · Cited by 159
Schertzer, J. W., Brown, S. A., & Whiteley, M. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07303.x · Cited by 159
Pseudomonas aeruginosaPqsA Is an Anthranilate-Coenzyme A Ligase
Coleman, J. P., Hudson, L. L., McKnight, S. L., Farrow, J. M., Calfee, M. W., Lindsey, C. A., & Pesci, E. C. (2007) · Journal of Bacteriology · doi:10.1128/jb.01140-07 · Cited by 158
Lee, K. K., Sheth, H. B., Wong, W. Y., Sherburne, R., Paranchych, W., Hodges, R. S., Lingwood, C. A., Krivan, H., & Irvin, R. T. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00348.x · Cited by 158
De, N., Navarro, M. V. A. S., Raghavan, R. V., & Sondermann, H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.030 · Cited by 157
Desmard, M., Davidge, K. S., Bouvet, O. M. M., Morin, D., Roux, D., Foresti, R., Ricard, J. D., Denamur, É., Poole, R. K., Montravers, P., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-122804 · Cited by 156
Interspecies Interaction between Pseudomonas aeruginosa and Other Microorganisms
Tashiro, Y., Yawata, Y., Toyofuku, M., Uchiyama, H., & Nomura, N. (2013) · Microbes and Environments · doi:10.1264/jsme2.me12167 · Cited by 156
McClerren, A. L., Endsley, S., Bowman, J. L., Andersen, N. H., Guan, Z., Rudolph, J., & Raetz, C. R. H. (2005) · Biochemistry · doi:10.1021/bi0518186 · Cited by 155
Nickeleit, I., Zender, S., Sasse, F., Geffers, R., Brandes, G., Sörensen, I., Steinmetz, H., Kubicka, S., Carlomagno, T., Menche, D., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.016 · Cited by 154
Aparna, V., Kesavan, D. K., Mohanalakshmi, N., Velmurugan, D., & Hopper, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101840 · Cited by 152
Sambanthamoorthy, K., Sloup, R. E., Parashar, V., Smith, J. M., Kim, E. E., Semmelhack, M. F., Neiditch, M. B., & Waters, C. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01396-12 · Cited by 151
A lipid zipper triggers bacterial invasion
Eierhoff, T., Bastian, B., Thuenauer, R., Madl, J., Audfray, A., Aigal, S., Juillot, S., Rydell, G. E., Müller, S. K., de Bentzmann, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402637111 · Cited by 151
Glycopeptide dendrimers as Pseudomonas aeruginosa biofilm inhibitors
Reymond, J., Bergmann, M., & Darbre, T. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35504g · Cited by 150
Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion
Aiello, D. A., Williams, J. D., Majgier-Báranowska, H., Patel, I. J., Peet, N. P., Huang, J., Lory, S., Bowlin, T. L., & Moir, D. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01598-09 · Cited by 150
Acquisition and Evolution of theexoULocus inPseudomonas aeruginosa
Kulasekara, B. R., Kulasekara, H. D., Wolfgang, M. C., Stevens, L., Frank, D. W., & Lory, S. (2006) · Journal of Bacteriology · doi:10.1128/jb.02000-05 · Cited by 149
Bokhove, M., Jimenez, P. N., Quax, W. J., & Dijkstra, B. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911839107 · Cited by 148
Pseudomonas aeruginosa elastase. Development of a new substrate, inhibitors, and an affinity ligand.
Nishino, N., & Powers, J. C. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85724-1 · Cited by 146
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Self-citationDifferent drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 256
Metadata
- Authors
- Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-18
- Volume
- 59
- Issue
- 13
- Pages
- 5929-5969
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2291776655
- Cited by
- 258
- References
- 337
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.